![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter and Conference Paper
Nicht-kleinzelliges Bronchialkarzinom mit pathologischem N2-Befall: Adjuvante Radiotherapie versus adjuvante Chemo-Radiotherapie / Adjuvant Chemo-Radiotherapy versus Radiotherapy Following Surgery in pN2-Non-small Cell Lung Cancer (NSCLC) Stage IIIa
Fifty-eight patients, 28 of them included in a German multicenter study, were treated either with radiotherapy (5×2 Gy/50 Gy) or combined radio-chemotherapy (cisplatin 75mg/m2 d1 in cases with pneumonectomy etopo...
-
Chapter and Conference Paper
Multimodales Therapiekonzept beim kleinzelligen Bronchialkarzinom im Stadium I – III A. Fallverlaufsstudie über 15 Jahre / Multimodality Treatment in LD-SCLC Including Surgery
We analysed our results of multimodal therapy including chemotherapy, radiotherapy and surgery in 150 consecutive patients with SCLC stage I-IIIa operated on in our hospital between 1983 and 2000. Median age: ...
-
Chapter and Conference Paper
Multimodale Therapieansätze bei der chirurgischen Therapie des Bronchialkarzinoms im Stadium III
In nonpretreated patients with tumor stage ‘limited disease,’ a combination of chemotherapy and radiotherapy leads to remission rates of 70%–95%. The mean survival time of patients is 12 months, in complete re...
-
Chapter and Conference Paper
Laser- und Afterloading-Therapie Bronchialkarzinom
Endobronchial afterloading irradiation by remote control was administered to 304 patients with lung cancer. The use of a highly active 192-Iridium source (740 GBq) is possible; irradiation time lasts only a fe...